• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  04/29/2011
Trade Name:  Nexium IV
Generic Name or Proper Name (*):  esomeprazole
Indications Studied:  Treatment of Gastroesophageal Reflux Disease (GERD) with erosive esophagitis
Label Changes Summary:  * Extended indication from adults to pediatric patients 1 month to 17 years * Use in pediatric patients 1 month to 17 years is supported by studies in adults, and PK and PD studies performed in pediatric patients* Effectiveness has not been established in patients less than 1 month of age* Information on dosing, adverse reactions, pharmacokinetics and clinical trial* Postmarketing study
Product Labeling:  Labeling  Opens a new window
Sponsor:  AstraZeneca
Therapeutic Category:  Antiulcerative